Merit Financial Group LLC Takes Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Merit Financial Group LLC purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 36,649 shares of the medical instruments supplier's stock, valued at approximately $548,000.

Several other large investors have also recently bought and sold shares of XRAY. Riverview Trust Co bought a new position in DENTSPLY SIRONA in the 4th quarter valued at $26,000. Colonial Trust Co SC bought a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth $26,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after acquiring an additional 1,568 shares during the last quarter. True Wealth Design LLC lifted its holdings in shares of DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock worth $41,000 after acquiring an additional 1,950 shares during the last quarter. Finally, Quarry LP lifted its holdings in shares of DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after acquiring an additional 780 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Performance

XRAY stock traded down $0.38 on Friday, hitting $15.63. The company had a trading volume of 1,408,937 shares, compared to its average volume of 2,966,305. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $27.95. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock's 50-day simple moving average is $14.85 and its 200 day simple moving average is $16.86. The stock has a market cap of $3.11 billion, a price-to-earnings ratio of -7.55, a P/E/G ratio of 1.80 and a beta of 0.95.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. During the same quarter last year, the company posted $0.42 earnings per share. The firm's quarterly revenue was down 7.8% on a year-over-year basis. As a group, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be given a $0.16 dividend. The ex-dividend date is Friday, June 27th. This represents a $0.64 annualized dividend and a yield of 4.09%. DENTSPLY SIRONA's payout ratio is presently -14.10%.

Wall Street Analyst Weigh In

Several research firms have weighed in on XRAY. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective on the stock. in a research report on Tuesday, April 15th. Wells Fargo & Company reduced their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Mizuho reduced their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Finally, UBS Group cut their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $20.36.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.